Sort
17,288 grants matching “multiple sclerosis”
Exploiting metabolic vulnerabilities of CD4 T cell subsets to control inflammatory disease
$379,054Jeffrey C Rathmell · Vanderbilt University Medical Center · R01 · FY2016 · DK
The Role of Arginine Methyltransferases in Interferon Signaling
$379,000Kerri A Mowen · Scripps Research Institute, The · R01 · FY2008 · GM
The Role of Arginine Methyltransferases in Interferon Signaling
$379,000Kerri A Mowen · Scripps Research Institute, The · R01 · FY2009 · GM
Analysis of the immunological role of Phospholipase D4
$379,000David Nemazee · Scripps Research Institute, The · R21 · FY2012 · AI
Role of Th1 specific cell surface molecule Tim-3 in EAE.
$378,985Vijay K Kuchroo · Brigham And Women'S Hospital · R01 · FY2010 · NS
Novel molecular mediators for activity-dependent myelination
$378,912Wenjing Sun · Ohio State University · R01 · FY2022 · NS
Immune Regulation of CNS Viral Recrudescence
$378,911Cornelia C Bergmann · Cleveland Clinic Lerner Com-Cwru · R01 · FY2009 · AI
Immune Regulation of CNS Viral Recrudescence
$378,911Cornelia C Bergmann · Cleveland Clinic Lerner Com-Cwru · R01 · FY2008 · AI
SIRPgamma: a novel checkpoint regulator of effector responses from human T-cells
$378,837Sushmita Sinha · Texas Woman'S University · R15 · FY2023 · AI
Using human IPS cells to study fate, function and neurodegenerative disease
$378,827Lorraine Iacovitti · Thomas Jefferson University · R01 · FY2017 · NS
Investigation of THC Receptors
$378,809Jenny L. Wiley · Virginia Commonwealth University · R01 · FY2008 · DA
Characterization of Fuctional Defective Autoimmune Human CD4+CD25+ Tregs
$378,794David A. Hafler · Brigham And Women'S Hospital · U19 · FY2007 · AI
Optic Nerve Myelination
$378,760Ben A Barres · Stanford University · R01 · FY2007 · EY
TNFR2 Sex Differences and EAE
$378,750John Roland Bethea · Drexel University · R01 · FY2023 · NS
Novel Mechanisms of C-Kit Regulation in Mast Cells
$378,750Reuben Kapur · Indiana Univ-Purdue Univ At Indianapolis · R01 · FY2006 · HL
TNFR2 Sex Differences and EAE
$378,750John Roland Bethea · Drexel University · R01 · FY2022 · NS
Myeloperoxidase, imaging biomarker and treatment target for multiple sclerosis
$378,748John W Chen · Massachusetts General Hospital · R01 · FY2011 · NS
The role of TNFR2 in ameliorating progressive encephalomyelitis
$378,743Thomas G. Forsthuber · University Of Texas San Antonio · R01 · FY2021 · NS
The role of TNFR2 in ameliorating progressive encephalomyelitis
$378,743Thomas G. Forsthuber · University Of Texas San Antonio · R01 · FY2023 · NS
The role of TNFR2 in ameliorating progressive encephalomyelitis
$378,743Thomas G. Forsthuber · University Of Texas San Antonio · R01 · FY2022 · NS
Myeloperoxidase, imaging biomarker and treatment target for multiple sclerosis
$378,731John W Chen · Massachusetts General Hospital · R01 · FY2012 · NS
Biochemical Mechanisms of Enzyme Action and Cellular Regulation
$378,721P. Boon Chock · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL
Pathogenic T Cells in Chronic Beryllium Disease
$378,711Andrew P Fontenot · University Of Colorado Denver · R01 · FY2011 · HL
Immunogenetic Studies of Autoimmune Disease
$378,682University Of California Berkeley · R01 · FY2004 · AI
Establishing VEP as a quantitative biomarker for remyelination using transgenic models for gain and loss of function
$378,649Ari J Green · University Of California, San Francisco · R01 · FY2018 · NS